Daily FNArena News

Gains in the resources, banking and technology sectors contributed to a 6.9% total return for the ASX200 in March, as Australia continued to outperform global equity markets

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Despite a big share price fall, Citi suggests it’s still not time to get back into Reliance Worldwide

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. While Stockland’s valuation has traditionally been linked to the residential housing cycle, Morgan Stanley sees new avenues of growth emerging

With fertiliser prices soaring due to Russian sanctions, Michael Gable of Fairmont Equities assesses the technicals for Incitec Pivot

Brokers discuss the longer term strategy for Eagers Automotive and the impacts of shorter term vehicle supply issues

Job placement company APM Human Services International has won new government contracts that could increase its foot print in Australia by 50%

Following FY21 results for Sigma Healthcare brokers see an uncertain outlook for near-term earnings

ResMed has struggled to realise the benefit promised by a major competitor recall and heightened demand amid a global shortage of semiconductor chips necessary for device production

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Following first half results for Premier Investments, brokers generally set higher target prices and noted leverage towards both stay-at-home and re-opening thematics